Meridian Bioscience (VIVO) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.87 --0%
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC: -84.07M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC: -84.07M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Meridian Bioscience (Nasdaq: VIVO) reported Q4 EPS of $0.19, in-line with the analyst estimate of $0.19. Revenue for the quarter came in at $48 million versus the consensus estimate of $46.2 million.
Meridian Bioscience reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
